Bio-Works Technologies AB's Nomination Committee shall consist of representatives of the three shareholders in the company in terms of voting rights who wish to be included in the Nomination Committee according to information from Euroclear Sweden AB as of the last banking day in September. The Nomination Committee has now been constituted and consists of the following members: Staffan Persson, Swedia Invest AB (Chairman of the Nomination Committee), Erik Åfors, Calyptra AB, Dariush Hosseinian, Karkas Captial AB.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.94 SEK | -.--% | +1.38% | -58.59% |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-58.59% | 10.43M | |
-3.72% | 184B | |
-2.60% | 107B | |
-3.79% | 67.78B | |
+2.66% | 50.66B | |
+16.39% | 47.64B | |
+4.60% | 41.12B | |
+1.38% | 26.3B | |
+1.52% | 26.04B | |
-1.17% | 24.71B |
- Stock Market
- Equities
- BIOWKS Stock
- News Bio-Works Technologies AB
- Bio-Works Technologies AB's Nomination Committee for the 2024 Annual General Meeting